Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients
暂无分享,去创建一个
R. Labianca | L. Frontini | V. Zagonel | M. Menghi | A. Ruzzo | S. Lonardi | A. Sobrero | F. Bergamo | F. Galli | L. Foltran | M. Ionta | N. Pella | M. Ronzoni | C. Mucciarini | V. Ricci | E. Veltri | A. Bramati | C. Verusio | P. Sozzi | I. Bagaloni | S. Lazzarelli | F. Galli | Edoardo Biondi | Sandro Barni | Francesco Graziano | Eliana Rulli | Bruno Massidda | Mario Nicolini | Daniele Turci | Mauro Magnani